Search Results 111-120 of 21248 for anti-TNF drugs

  1. centers-of-excellence

    Adalimumab-Adbm (Subcutaneous Route) Before Using - Mayo Clinic. Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo ...

  2. Osteoporosis treatment: Medications can help - Mayo Clinic

    Find out more about your options for bone-preserving drugs, including how often you need to take them and what side effects you might expect.

  3. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

  4. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

  5. Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients - Mayo Clinic News Network

    Researchers tested blood samples taken before rheumatoid arthritis treatment was given. The patients then were treated with anti-inflammatory biologic drugs ...

  6. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

    ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

  7. NSAIDs: Do they increase my risk of heart attack and stroke? - Mayo Clinic

    Answer From Rekha Mankad, M.D.. Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) — medications commonly used to treat pain and inflammation — can increase the ...

  8. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

  9. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  10. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...